Why Merck Just Slashed Its Profit Outlook By Nearly 50%
Merck & Co. Inc. (NYSE: MRK ) stock edged higher Tuesday after the drugmaker reported second-quarter results that topped Wall Street revenue expectations and posted a smaller-than-expected adjusted loss, while raising its full-year sales guidance despite recording multibillion-dollar acquisition-related charges. Merck